1.2 VASCULAR CALCIFICATIONS AFTER CHRONIC USE OF VITAMIN-K ANTAGONISTS
Background: Arterial calcification is commonly observed in cardiovascular disease and is associated with increased arterial stiffness, systolic hypertension and adverse cardiovascular outcome. Arterial calcification is an actively regulated process with several stimulating and inhibiting factors. An...
Main Authors: | B.J. van Varik, R.J.M.W. Rennenberg, A.A. Kroon, L.J. Schurgers, P.W. de Leeuw |
---|---|
Format: | Article |
Language: | English |
Published: |
Atlantis Press
2009-12-01
|
Series: | Artery Research |
Online Access: | https://www.atlantis-press.com/article/125927349/view |
Similar Items
-
Vitamin K Antagonists, Non–Vitamin K Antagonist Oral Anticoagulants, and Vascular Calcification in Patients with Atrial Fibrillation
by: Frederique E. C. M. Peeters, et al.
Published: (2018-10-01) -
Pharmacological and Nutritional Modulation of Vascular Calcification
by: Liv M. Vossen, et al.
Published: (2019-12-01) -
Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis
by: R J M W Rennenberg, et al.
Published: (2009-01-01) -
Vitamin K Antagonist Use and Risk for Intracranial Carotid Artery Calcification in Patients With Intracerebral Hemorrhage
by: Michaël T. J. Peeters, et al.
Published: (2019-12-01) -
Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial)
by: Liv M. Vossen, et al.
Published: (2015-10-01)